ICP
TXG icon

Interchange Capital Partners’s 10x Genomics TXG Stock Holding History

Interchange Capital Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Buy
19,184
+4,609
+32% +$121K 0.14% 150
2026
Q1 		$178K Sell
14,575
-15,272
-51% -$305K 0.06% 273
2025
Q4 		$487K Buy
29,847
+5,669
+23% +$85.6K 0.09% 206
2025
Q3 		$283K Buy
24,178
+13,675
+130% +$178K 0.06% 274
2025
Q2 		$122K Sell
10,503
-1,013
-9% -$9.23K 0.03% 276
2025
Q1 		$101K Sell
11,516
-1,121
-9% -$14.1K 0.03% 266
2024
Q4 		$175K Buy
12,637
+14
+0.1% +$221 0.06% 244
2024
Q3 		$285K Buy
+12,623
New +$261K 0.1% 205
2024
Q2 		– Sell
-5,411
Closed -$208K – 291
2024
Q1 		$208K Buy
+5,411
New +$238K 0.14% 157
2022
Q1 		– Sell
-1,888
Closed -$281K – 176
2021
Q4 		$281K Buy
+1,888
New +$289K 0.28% 119
2021
Q2 		– Sell
-2,116
Closed -$450K – 213
2021
Q1 		$450K Buy
2,116
+2,092
+8,717% +$361K 0.24% 130
2020
Q4 		$3K Buy
+24
New +$3.48K ﹤0.01% 1038

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Interchange Capital Partners's TXG Position: Q2 2026 in Review

Interchange Capital Partners increased its 10x Genomics (TXG) stake by 32% in Q2 2026, buying an estimated $121K and bringing the position to 19,184 shares worth $736K. The position accounts for 0.14% of the portfolio, ranked #150.

Interchange Capital Partners first reported a position in TXG in Q4 2020 and has held it in 12 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Interchange Capital Partners held 19,184 shares of 10x Genomics worth $736K as of Q2 2026.
  • Interchange Capital Partners bought 4,609 10x Genomics shares in Q2 2026, an estimated $121K.
  • 10x Genomics made up 0.14% of Interchange Capital Partners's portfolio in Q2 2026, its #150 holding.
  • Interchange Capital Partners first reported a position in 10x Genomics in Q4 2020 and has held it in 12 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.